1884461-72-6 ensifentrine

Pwopriyete

Aparans limyè jòn poud vèt jòn
Dansite 1.29 ± 0. 1 g\/cm3
Depo tanperati. Magazen nan -20 degre
Solubility DMSO: 25 mg\/ml (52,35 mm; bezwen ultrason)

 

Aplikasyon:

Ensifentrine se sitou itilize pou terapi antretyen nan tretman an nan maladi kwonik pilmonè blokis (COPD). Ensifentrine se yon terapi rale roman ki gen efè doub nan bronchiectasis ak steroidyen anti-enflamatwa pa anpeche fosfodiesteraz 3 (PDE3) ak fosfodiesteraz 4 (PDE4).

 

Sinonim:

298680-25-8

N-(2- (6, 7- dihydro -9, 10- dimethoxy -4- oxo -2- (2,4, 6- trimethy lphenyl) imino) -2 h-pyrimido (6, 1- a) isoquinolin -3 (4H) -yl) etil) urea

Ensifentrine

Rpl -554

1884461-72-6

(E\/Z) -Esifentrine

2- [9, 10- dimethoxy -4- oxo -2- (2,4, 6- trimethylphenyl) Imino -6, 7- dihydropyrimido [6, 1- a] isoquinolin -3- yl] ethylurea

(E) -1- (2- (2- (mesitylimino) -9, 10- dimethoxy -4- oxo -6, {{{{{{{{{{{{{ 7}} dihydro -2 h-pyrimido [6, 1- a] isoquinolin -3 (4h) -yl) etil) urea urea

9, 10- dimethoxy -2- (2,4, 6- trimethylphenylimino) -3- (n-carbamoyl -2- Aminoe Thyl) -3, 4,6, 7-

N-(2- ((2e) -9, 10- dimetoxi -4- oxo -2- ((2,4, 6- trimetilfenil) imino) {{1 0}}, 7- dihidro -2 H-pirimido (6, 1- a) isoquinolein -3 (4h) -il) etil) urea

Ure, N-(2- (6, 7- dihydro -9, 10- dimethoxy -4- oxo -2- ((2,4, 6- trimet hylphenyl) imino) -2 h-pyrimido (6, 1- a) isoquinolin -3 (4h) -yl) etil)-

 

 

Baj popilè: 1884461-72-6 Ensifentrine, Lachin 1884461-72-6 Ensifentrine Konpayi fabrikasyon, Swèd